Please login to the form below
FCA
This page shows the latest FCA news and features for those working in and with pharma, biotech and healthcare.
UK financial authority confirms Woodford probe
The Financial Conduct Authority (FCA) is looking into the factors that led to a block on money coming in or going out of the Woodford Equity Income Fund (WEIF) on 3 ... The FCA confirms the investigation is ongoing but won’t comment any further, and
Latest news
-
Novartis' Ilaris launched in UK
CAPS includes three auto-inflammatory disorders of increasing severity: familial cold auto-inflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), and neonatal-onset multisystem inflammatory disease (NOMID).
-
FDA Approves drug for rare disease
Arcalyst, which is manufactured by Regeneron Pharmaceuticals, was approved for the long-term treatment of Cryopyrin-associated periodic syndromes (CAPS) disorders such as familial cold auto-inflammatory syndrome (FCAS) and
More from news
Approximately 1 fully matching, plus 2 partially matching documents found.
Latest Intelligence
-
Rise of generics will curb France’s pharma growth
Sanofi, Schering-Plough (wholly owned by MSD since 2009) and Janssen are among the companies the French Competition Authority (FCA) has launched enquiries into for this over the last few years. ... The government and the FCA contend, however, that
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Sanofi's frexalimab shows promise in relapsing forms of MS
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Amgen reports positive results for Otezla in psoriatic arthritis
- Supply chain challenges in 2023
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
Anthem PR
With a rare strength in media and influencer relations, Anthem’s award-winning team offers a fresh approach to health PR...
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
